Related Experiment Videos
Defense mechanisms against infections.
1Department of Medicine, Pennsylvania State University, College of Medicine, Hershey 17033, USA.
Current Opinion in Pulmonary Medicine
|May 6, 1999
Summary
New strategies are needed to combat respiratory infections like Streptococcus pneumoniae pneumonia, especially in vulnerable populations. Research focuses on novel vaccination methods targeting airway immune cells and utilizing cytokines to enhance immune responses.
Area of Science:
- Immunology
- Infectious Diseases
- Respiratory Medicine
Background:
- Respiratory infections are increasingly difficult to treat due to emerging microbes, opportunistic pathogens, and rising antibiotic resistance, particularly in Streptococcus pneumoniae.
- Pneumonia severity is exacerbated by a growing population of susceptible hosts, including immunocompromised individuals (due to medical therapy or HIV) and the elderly with comorbidities.
Purpose of the Study:
- To address the need for improved strategies against respiratory infections, focusing on enhancing host defenses and developing novel vaccination approaches.
- To explore innovative methods for immunizing the respiratory mucosal surface against pathogens like Streptococcus pneumoniae.
Main Methods:
- Investigating antigen-targeting strategies to deliver relevant antigens to airway antigen-processing cells, such as dendritic cells.
- Exploring the use of immunomodulatory cytokines, like interleukin-12, to enhance mucosal immune responses.
Main Results:
- Interleukin-12 demonstrates potential in stimulating mucosal antibody production (S-IgA and IgG) and promoting T lymphocyte responses.
- Interferon-gamma, induced by interleukin-12, can enhance macrophage-mediated microbial killing.
Conclusions:
- Novel vaccination strategies targeting respiratory mucosal surfaces are crucial for combating infections like Streptococcus pneumoniae.
- Utilizing cytokines such as interleukin-12 offers a promising avenue for boosting mucosal immunity and improving treatment outcomes for respiratory infections.